To evaluate the potential of cf-mRNA to monitor the activity of specific BM lineages after stimulation with growth factors, we obtained plasma from nine patients with varying degrees of chronic kidney failure on chronic maintenance erythropoietin (EPO) therapy. The gene discussed is EPO; the disease is chronic renal failure syndrome.